January 29, 2014
A Maryland federal judge on Wednesday threw out Classen Immunotherapies Inc.'s lawsuit against Merz Pharmaceuticals LLC and Shionogi Inc. over infringement of two patents covering a system to determine the efficacy and side effects of medication, holding that the defendants are protected by a statutory safe harbor provision.